Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 6;22(2):488.
doi: 10.3390/ijms22020488.

Flavonoids: Nutraceuticals for Rheumatic Diseases via Targeting of Inflammasome Activation

Affiliations
Review

Flavonoids: Nutraceuticals for Rheumatic Diseases via Targeting of Inflammasome Activation

Young-Su Yi. Int J Mol Sci. .

Abstract

Inflammation, an innate immune response that prevents cellular damage caused by pathogens, consists of two successive mechanisms, namely priming and triggering. While priming is an inflammation-preparation step, triggering is an inflammation-activation step, and the central feature of triggering is the activation of inflammasomes and intracellular inflammatory protein complexes. Flavonoids are natural phenolic compounds predominantly present in plants, fruits, and vegetables and are known to possess strong anti-inflammatory activities. The anti-inflammatory activity of flavonoids has long been demonstrated, with the main focus on the priming mechanisms, while increasing numbers of recent studies have redirected the research focus on the triggering step, and studies have reported that flavonoids inhibit inflammatory responses and diseases by targeting inflammasome activation. Rheumatic diseases are systemic inflammatory and autoimmune diseases that primarily affect joints and connective tissues, and they are associated with numerous deleterious effects. Here, we discuss the emerging literature on the ameliorative role of flavonoids targeting inflammasome activation in inflammatory rheumatic diseases.

Keywords: anti-inflammatory; flavonoids; inflammasomes; nutraceuticals; rheumatic diseases.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
Ameliorative role of flavonoids in rheumatic diseases by inhibiting inflammasome activation. Icariin, procyanidin B2, trans-Chalcone, HMC, procyanidins, morin, EGCG, ferulic acid, and catechin play an anti-inflammatory role and alleviate GA in GA animal models and macrophages. Baicalein, icariin, procyanidin B2, and EGCG play an anti-inflammatory role and alleviate LN in lupus animal models and MDSCs. Quercetin and naringenin play anti-inflammatory roles and alleviate RA in RA animal and cell models. HMC, hesperidin methylchalcone; EGCG, epigallocatechin-3-gallate; GA, gouty arthritis; LN, lupus nephritis; RA, rheumatoid arthritis.

Similar articles

Cited by

References

    1. Janeway C.A., Jr., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002;20:197–216. doi: 10.1146/annurev.immunol.20.083001.084359. - DOI - PubMed
    1. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805–820. doi: 10.1016/j.cell.2010.01.022. - DOI - PubMed
    1. Chen L., Deng H., Cui H., Fang J., Zuo Z., Deng J., Li Y., Wang X., Zhao L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9:7204–7218. doi: 10.18632/oncotarget.23208. - DOI - PMC - PubMed
    1. Yi Y.S. Folate Receptor-Targeted Diagnostics and Therapeutics for Inflammatory Diseases. Immune Netw. 2016;16:337–343. doi: 10.4110/in.2016.16.6.337. - DOI - PMC - PubMed
    1. Duan L., Rao X., Sigdel K.R. Regulation of Inflammation in Autoimmune Disease. J. Immunol. Res. 2019;2019:7403796. doi: 10.1155/2019/7403796. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources